Global Calcium Glycinate Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

What is the Calcium Glycinate Market Size and Growth Rate?

• As per Data Bridge Market Research analysis, the calcium glycinate market was valued at USD 460.00 million in 2025 and is projected to reach USD 808.26 million by 2033, growing at a CAGR of 7,30% from 2026 to 2033.
• The market is experiencing consistent growth driven by rising awareness of bone health and calcium deficiency, increasing demand for highly bioavailable mineral supplements, and expanding applications of calcium glycinate across nutraceutical, pharmaceutical, and functional food industries.
• The increasing prevalence of calcium deficiencies globally, combined with growing consumer preference for easily absorbed and gastrointestinal-friendly mineral supplements, is compelling dietary supplement manufacturers and pharmaceutical companies to adopt calcium glycinate in their formulations. Its chelated structure, improved absorption characteristics, and compatibility with different dosage forms are supporting its adoption in preventive healthcare, nutritional supplementation, and fortified food products.

Market Size & Forecast

• Global Market Value (2025): USD 460.00 Million
• Expected Market Value (2033): USD 808.26 Million
• Forecast CAGR (2026–2033): 7.30%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

What are the Major Takeaways of the Calcium Glycinate Market?

• North America dominated the calcium glycinate market with the largest revenue share of 35.0% in 2025, supported by high consumer awareness of nutritional deficiencies, established dietary supplement industries, and strong demand for premium mineral supplements.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.5% from 2026 to 2033, fueled by rising health consciousness, increasing disposable incomes, expanding nutraceutical industries, and growing demand for bone health supplements in China, India, and Japan.
• The synthetic segment led the market with a 58.5% share in 2025, driven by its established manufacturing processes, consistent product quality, and ability to support large-scale commercial production.
• Fermentation-derived are the fastest-growing source type, projected to register a CAGR of 7.4%, reflecting the surge in interest in biotechnology-based production processes and sustainable manufacturing practices.
• The dry segment dominated the form category with a 64.7% revenue share in 2025, led by its longer shelf life, convenient storage, and compatibility with different supplement formulations.
• Pharmaceuticals/nutraceuticals accounted for 38.2% of the market share in 2025, preferred by increasing demand for mineral supplements and growing awareness of calcium deficiency and bone health
• The feed additives segment is the fastest-growing application category, with a CAGR of 7.8%, driven by increasing demand for mineral-enriched animal nutrition and improved livestock health.

Report Scope and Calcium Glycinate Market Segmentation  

What is the Key Trend in the Calcium Glycinate Market?

• Nutraceutical manufacturers are increasingly focusing on amino acid-chelated calcium formulations to improve mineral bioavailability, support bone health, and develop differentiated nutritional supplements for consumers seeking effective calcium supplementation.
• For instance, in April 2025, Econ Healthcare introduced ECAL PLUS, a calcium supplement containing 250 mg of elemental calcium from a lysine-bound calcium complex, highlighting growing industry interest in amino acid-based calcium formulations.
• Growing research interest in calcium bioaccessibility is encouraging manufacturers to explore alternative calcium sources and formulations for improved nutritional delivery across different food and supplement matrices.
• Dietary supplement companies are expanding their product portfolios with calcium-based formulations combined with vitamin D3, magnesium, and other essential nutrients to address multiple nutritional requirements through a single product.
• For instance, in February 2024, Nestlé India launched Resource Activ, a nutritional supplement enriched with calcium and vitamin D for bone health, alongside proteins, fiber, and other functional nutrients.
• As consumers increasingly prioritize preventive healthcare and effective mineral supplementation, the demand for specialized calcium formulations, including calcium glycinate, is expected to increase, strengthening innovation across the nutraceutical and functional nutrition industries.

What are the Key Drivers of the Calcium Glycinate Market?

• The increasing prevalence of inadequate dietary calcium intake and growing awareness of bone health have significantly increased demand for highly bioavailable calcium supplements, including amino acid-chelated mineral formulations.
• For instance, in November 2024, a study published in the Indian Journal of Endocrinology and Metabolism reported that only 21.3% of 291 healthy urban North Indian adults consumed calcium above the recommended dietary allowance, highlighting substantial nutritional gaps.
• Nutraceutical manufacturers and pharmaceutical companies are incorporating calcium into specialized nutritional formulations to address deficiencies, support skeletal health, and meet the growing demand for preventive healthcare products.
• For instance, in September 2025, Bayer launched Supradyn Mom's and Supradyn Naturals Calcium+ in India, targeting nutritional gaps among women during preconception, pregnancy, and lactation
• With increasing nutritional awareness and demand for advanced mineral supplementation, calcium glycinate is positioned to benefit from the expansion of preventive healthcare, nutraceutical innovation, and specialized nutritional products.

What Factors are Challenging the Growth of the Calcium Glycinate Market?

• Calcium glycinate production involves specialized chelation processes, stringent raw material quality requirements, and controlled manufacturing conditions, increasing production complexity compared with conventional calcium salts.
• For instance, in August 2024, the U.S. Food and Drug Administration (FDA) issued a Form 483 following an inspection of Global Calcium's manufacturing facility in India, identifying six observations involving manufacturing documentation, batch records, quality testing, and facility maintenance. These compliance deficiencies highlight the challenges associated with maintaining stringent manufacturing standards and consistent product quality in the calcium ingredient supply chain.
• These manufacturing requirements and relatively higher formulation costs can limit adoption among price-sensitive consumers, smaller supplement manufacturers, and companies operating in emerging markets.
• Manufacturers must also meet product safety, quality, labelling, and ingredient compliance requirements across different geographical markets, increasing regulatory and operational responsibilities.
• For instance, in October 2024, India's Central Drugs Standard Control Organisation (CDSCO) flagged select batches of Shelcal 500, a widely used calcium supplement, as spurious during its drug quality surveillance. The regulator's findings highlight quality-control challenges in calcium supplement manufacturing and the importance of product authentication, testing, and regulatory compliance, potentially increasing quality assurance costs for manufacturers
• The specialized manufacturing requirements, regulatory compliance costs, and competition from established calcium sources such as calcium carbonate and calcium citrate continue to challenge market expansion, particularly in cost-sensitive markets where conventional calcium supplements have wider availability

How is the Calcium Glycinate Market Segmented?

The calcium glycinate market is segmented on the basis of source, form, application, and end user.

• By Source

On the basis of source, the calcium glycinate market is segmented into fermentation-derived and synthetic. The synthetic segment dominated the market with an estimated 58.5% share in 2025, owing to its established manufacturing processes, consistent product quality, and ability to support large-scale commercial production. Synthetic production allows manufacturers to maintain controlled calcium and glycine concentrations during the chelation process. It also offers better consistency in product purity and batch-to-batch composition. The availability of established chemical manufacturing infrastructure supports its widespread commercial application. Furthermore, predictable production costs and scalability make synthetic calcium glycinate attractive to pharmaceutical and nutraceutical manufacturers.

The fermentation-derived segment is projected to register the fastest growth at an estimated CAGR of 7.4% from 2026 to 2033, driven by increasing interest in biotechnology-based production processes and sustainable manufacturing practices. Fermentation-based production offers opportunities to optimize raw material utilization and improve process efficiency. Growing demand for naturally positioned and biotechnology-derived nutritional ingredients is encouraging manufacturers to explore alternative production methods. Advancements in microbial fermentation and process optimization are supporting improvements in production consistency. Increasing emphasis on sustainable ingredient sourcing is also creating opportunities for fermentation-derived calcium compounds. Rising interest in innovative mineral production technologies is expected to accelerate adoption across specialized nutraceutical applications.

• By Form

On the basis of form, the calcium glycinate market is segmented into dry and liquid. The dry segment dominated the market with an estimated 64.7% share in 2025, owing to its longer shelf life, convenient storage, and compatibility with different supplement formulations. Dry calcium glycinate is widely incorporated into tablets, capsules, powdered nutritional blends, and mineral premixes. Its relatively low transportation and storage requirements make it commercially attractive for manufacturers and distributors. The powder-based format also allows precise ingredient blending with vitamins and other essential minerals. Furthermore, its suitability for large-scale nutraceutical and pharmaceutical manufacturing supports widespread adoption.

The liquid segment is projected to register the fastest growth at an estimated CAGR of 7.6% from 2026 to 2033, driven by increasing demand for convenient and easy-to-consume nutritional formulations. Liquid calcium glycinate offers flexibility in dosage administration and can be incorporated into nutritional liquids and specialized supplement formulations. It is particularly suitable for consumers who experience difficulty swallowing conventional tablets and capsules. Growing demand for liquid nutritional products among children and elderly consumers is supporting segment expansion. Advancements in liquid formulation stability and delivery technologies are further improving product development opportunities. Increasing consumer preference for convenient supplementation formats is expected to accelerate the adoption of liquid calcium glycinate.

• By Application

On the basis of application, the calcium glycinate market is segmented into pharmaceuticals/nutraceuticals, food additives, feed additives, and personal care products. The pharmaceuticals/nutraceuticals segment dominated the market with an estimated 38.2% share in 2025, driven by increasing demand for mineral supplements and growing awareness of calcium deficiency and bone health. Calcium glycinate is gaining attention as an alternative calcium source in specialized nutritional formulations. Its chelated composition and potential gastrointestinal tolerability make it attractive for supplement development. Pharmaceutical and nutraceutical manufacturers are incorporating calcium-based ingredients into formulations targeting skeletal health and nutritional deficiencies. Increasing demand for preventive healthcare products is further supporting segment growth.

The feed additives segment is projected to register the fastest growth at an estimated CAGR of 7.8% from 2026 to 2033, driven by increasing demand for mineral-enriched animal nutrition and improved livestock health. Calcium plays an essential role in bone development, skeletal strength, and metabolic functions in livestock. Growing awareness of balanced mineral nutrition is encouraging feed manufacturers to explore specialized calcium sources. Increasing commercial livestock production is creating demand for nutritionally optimized feed formulations. Advancements in animal nutrition and mineral supplementation are further supporting the development of innovative feed additives. Rising emphasis on livestock productivity, reproductive health, and animal well-being is expected to accelerate the adoption of calcium-based feed ingredients.

• By End User

On the basis of end user, the calcium glycinate market is segmented into adults, athletes, children and adolescents, geriatric population, and pregnant women. The adults segment dominated the market with an estimated 52.1% share in 2025, supported by increasing awareness of calcium requirements and growing consumption of nutritional supplements for maintaining bone health. Adults increasingly incorporate calcium supplements into their daily preventive healthcare routines. Rising awareness of nutritional deficiencies and lifestyle-related health concerns is encouraging regular mineral supplementation. Calcium glycinate is gaining attention among consumers seeking alternative calcium formulations with favorable absorption characteristics. Growing availability of combination supplements containing calcium, vitamin D3, and other essential minerals is further supporting demand.

The geriatric population segment is projected to register the fastest growth at an estimated CAGR of 8.1% from 2026 to 2033, driven by increasing age-related bone health concerns and rising demand for specialized nutritional supplementation. Older adults are more susceptible to declining bone mineral density and calcium deficiency. Growing awareness of osteoporosis and age-related skeletal disorders is encouraging the adoption of calcium-based nutritional products. Calcium glycinate is attracting attention as a potential ingredient in formulations designed for individuals seeking alternative calcium supplementation options. Increasing demand for easy-to-consume and gastrointestinal-friendly supplement formats is further supporting this segment. Expanding geriatric healthcare services and preventive nutrition initiatives are expected to accelerate demand for calcium supplementation among older consumers.

Which Region Holds the Largest Share of the Calcium Glycinate Market?

• North America dominated the calcium glycinate market with the largest revenue share of 35.0% in 2025, supported by high consumer awareness of nutritional deficiencies, established dietary supplement industries, and strong demand for premium mineral supplements.
• The region also benefits from increasing preventive healthcare spending, widespread availability of specialized mineral supplements, and growing consumer interest in bone health and nutritional wellness. Rising adoption of chelated mineral formulations, expanding e-commerce distribution networks, and continuous product innovation across the dietary supplement industry continue to strengthen North America's leadership position in the global market.

U.S. Calcium Glycinate Market Insight

The U.S. calcium glycinate market is witnessing strong growth due to rising consumer awareness of calcium deficiency, increasing demand for advanced dietary supplements, and growing emphasis on preventive healthcare. The country's well-established nutraceutical industry, along with increasing adoption of chelated mineral formulations, is driving demand across pharmaceutical and nutritional applications. In addition, growing concerns regarding bone health, osteoporosis prevention, and age-related calcium deficiencies are accelerating the adoption of specialized calcium supplements among consumers.

Asia-Pacific Calcium Glycinate Market Insight

The Asia-Pacific calcium glycinate market is expected to witness rapid growth, driven by increasing health consciousness, expanding nutraceutical manufacturing, and rising demand for mineral supplements across countries such as China, India, and Japan. Growing awareness of calcium deficiency, rising disposable incomes, and increasing consumption of fortified foods and dietary supplements are supporting regional market expansion. In addition, the growing presence of pharmaceutical manufacturers and expanding online supplement distribution networks are accelerating the adoption of specialized calcium formulations.

Japan Calcium Glycinate Market Insight

The Japan calcium glycinate market is witnessing consistent growth due to rising demand for nutritional supplements, increasing awareness of age-related bone health concerns, and the country's rapidly aging population. Nutraceutical manufacturers are increasingly focusing on advanced mineral formulations to address calcium deficiencies and support skeletal health among older consumers. Moreover, growing interest in preventive healthcare, functional nutrition, and convenient supplement delivery formats is further contributing to market growth in Japan.

China Calcium Glycinate Market Insight

The China calcium glycinate market is growing rapidly, driven by increasing consumer awareness of nutritional deficiencies, expanding dietary supplement consumption, and rising demand for premium mineral formulations. Growing urbanization, improving disposable incomes, and increasing emphasis on bone health are significantly boosting market demand. In addition, expanding nutraceutical manufacturing capabilities, rising adoption of fortified food products, and growing e-commerce distribution are positioning China as an important growth market for calcium glycinate.

U.K. Calcium Glycinate Market Insight

The U.K. calcium glycinate market is experiencing steady growth, supported by rising consumer interest in preventive nutrition, increasing demand for specialized dietary supplements, and growing awareness of calcium deficiency. The country's established food supplement industry and increasing preference for premium mineral formulations are contributing to market expansion. Furthermore, growing demand for convenient supplement formats, greater focus on healthy aging, and expanding online retail channels are supporting the adoption of calcium glycinate across the U.K.

Germany Calcium Glycinate Market Insight

The Germany calcium glycinate market is expanding steadily due to the country's strong pharmaceutical and nutraceutical manufacturing base, increasing consumer focus on nutritional wellness, and rising demand for high-quality mineral supplements. Supplement manufacturers are increasingly exploring specialized calcium formulations to address bone health and nutritional deficiencies. Continuous innovation in ingredient processing, growing demand for functional nutrition products, and strong emphasis on product quality and regulatory compliance are further supporting market development in Germany.

Which are the Top Companies in Calcium Glycinate Market?

The calcium glycinate industry is primarily led by well-established companies, including:

• Global Calcium Pvt. Ltd. (India)
• West Bengal Chemical Industries Limited (India)
• Dr. Paul Lohmann GmbH & Co. KGaA (Germany)
• Beijing FortuneStar S&T Development Co., Limited (China)
• Adhiron (U.K.)
• ELIS Biotech (China)
• Greenyn Biotechnology Co., Ltd. (Taiwan)
• Cypress Minerals (U.S.)
• Newseed Chemical Co., Limited (China)
• Aditya Chemicals (India)
• Advancein Organics LLP (India)
• Shijiazhuang Donghua Jinlong Chemical Co., Ltd. (China)
• Hebei Huaheng Biological Technology Co., Ltd. (China)
• Hebei LiWellso Biotech Co., Ltd. (China)
• Shanpar Industries Pvt. Ltd. (India)
• Simagchem Corporation (China)
• Shanghai Jinhuan Chemical Co., Ltd. (China)
• Papchem Lifesciences (India)
• Hefei TNJ Chemical Industry Co., Ltd. (China)
• Balchem Corporation (U.S.)

What are Latest Developments in Calcium Glycinate Market?

• In July 2025, Interclinical Laboratories received Australian Register of Therapeutic Goods (ARTG) registration for Calcium Plus, a nutritional formulation containing calcium glycinate, vitamin D3, vitamin K2, and other supporting ingredients. The registration highlights the commercialization of calcium glycinate-based formulations for bone health and nutritional supplementation. This development reflects growing interest in specialized calcium combinations and expands the availability of calcium glycinate-containing products in the Australian healthcare market.
• In January 2024, Richen Nutritional officially inaugurated its new amino acid chelate production line at its minerals workshop in China. The facility was designed to manufacture several mineral chelates, including calcium glycinate, magnesium glycinate, zinc glycinate, and ferrous glycinate, with an expected production capacity of 500 tons annually. The expansion strengthens the company's manufacturing capabilities and supports the availability of specialized chelated mineral ingredients for nutritional and industrial applications.
• In October 2023, the U.S. Department of Commerce issued a scope ruling concerning calcium glycinate in an investigation involving glycine imports from India, China, and Japan. The ruling determined that calcium glycinate was not covered by the existing antidumping and countervailing duty orders on glycine because it was considered a precursor of glycine rather than a type of glycine. This decision provided greater clarity regarding the trade classification and regulatory treatment of calcium glycinate in international markets.
• In July 2022, Australia's Therapeutic Goods Administration (TGA) registered Calcium Plus, manufactured by Interclinical Laboratories, as a therapeutic product containing calcium glycinate alongside vitamin D3, vitamin K2, and other ingredients. The registration demonstrates the use of calcium glycinate in commercially formulated nutritional products targeting bone health. This development also highlights the growing presence of chelated calcium ingredients in specialized supplement formulations.
• In August 2021, a patent for a process to prepare high-purity calcium glycinate using electrochemical-complexation reaction technology was granted in China. The invention, developed by Guangxi Academy of Sciences, focuses on improving calcium glycinate production through an electrochemical preparation process. This technological development highlights ongoing innovation in manufacturing methods, product purity, and processing efficiency for specialized calcium compounds.